IL10 and Sepsis: Targeted effects of melatonin on different cytokines in response to LPS sepsis in mice demonstrated that mice treated with the immunomodulator had much higher survival rates (90% vs 20%), and those pro-inflammatory cytokines such as TNF-α, IFN-γ, and IL-12 were reduced, the anti-inflammatory IL-10 was significantly raised47.